For the quarter ending 2026-03-31, ECL had -$126,400K decrease in cash & cash equivalents over the period. $97,400K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income including noncontrolling interest | 436,600 | 568,600 | 589,700 | 528,500 |
| Depreciation | 180,500 | 178,800 | 165,900 | 166,700 |
| Amortization | 82,600 | 77,300 | 76,600 | 75,000 |
| Deferred income taxes | 19,400 | 23,700 | 3,600 | -39,700 |
| Share-based compensation expense | 40,300 | 27,100 | 33,600 | 33,700 |
| Pension and postretirement plan contributions | 18,100 | 10,700 | 38,100 | 13,400 |
| Pension and postretirement plan (income) expense, net | 9,100 | 4,600 | 3,500 | 3,500 |
| Restructuring charges, net of cash paid | 3,500 | 31,300 | -17,900 | -16,400 |
| Sale of global surgical solutions business | - | 0 | 0 | 0 |
| Other, net | -10,600 | -8,400 | -13,600 | -11,200 |
| Accounts receivable | -13,500 | 35,600 | 27,900 | 113,300 |
| Inventories | 47,300 | -74,000 | -39,300 | 7,800 |
| Other assets | 117,200 | -49,500 | -11,800 | -52,200 |
| Accounts payable | 15,500 | 115,500 | -55,200 | 9,900 |
| Other liabilities | -183,100 | -22,400 | -7,200 | 11,700 |
| Cash provided by operating activities | 445,900 | 1,090,100 | 791,300 | 701,800 |
| Capital expenditures | 348,500 | 332,100 | 261,600 | 216,700 |
| Property and other assets sold | 200 | 5,900 | 4,000 | 20,800 |
| Acquisitions and investments in affiliates, net of cash acquired | - | 1,620,800 | 0 | 500 |
| Divestiture of businesses, net of cash divested | - | 0 | 0 | 0 |
| Other, net | 7,200 | 31,200 | 23,000 | 28,000 |
| Cash used for investing activities | -355,500 | -1,978,200 | -280,600 | -224,400 |
| Net issuances of commercial paper and notes payable | 201,600 | 97,100 | 1,900 | -5,300 |
| Long-term debt borrowings | 53,000 | 26,600 | 519,000 | 500,000 |
| Long-term debt repayments | - | 0 | 674,200 | - |
| Reacquired shares | 344,400 | 409,200 | 175,400 | 45,500 |
| Dividends paid | 215,900 | 189,200 | 184,400 | 188,000 |
| Exercise of employee stock options | 83,500 | 46,200 | 43,000 | 40,500 |
| Other, net | -3,600 | -3,100 | -7,300 | -4,400 |
| Cash used for financing activities | -225,800 | -431,600 | -477,400 | 297,300 |
| Effect of exchange rate changes on cash and cash equivalents | 9,000 | 10,100 | 1,600 | -16,400 |
| Decrease in cash and cash equivalents | -126,400 | -1,309,600 | 34,900 | 758,300 |
| Cash and cash equivalents, beginning of period | 646,200 | 1,955,800 | 1,920,900 | 1,162,600 |
| Cash and cash equivalents, end of period | 519,800 | 646,200 | 1,955,800 | 1,920,900 |
ECOLAB INC. (ECL)
ECOLAB INC. (ECL)